This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Reliv International Reports Fourth-Quarter And Full-Year Financial Results For 2013

Stocks in this article: RELV

CHESTERFIELD, Mo., March 5, 2014 (GLOBE NEWSWIRE) -- Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2013.

Fourth-Quarter Results

Reliv reported net sales of $17.4 million for the fourth quarter of 2013, compared with net sales of $16.9 million for the fourth quarter of 2012. U.S. net sales increased by 4.1 percent for the quarter compared with the same quarter in 2012. International net sales for the quarter decreased 1.5 percent compared to the prior-year quarter, but sales were buoyed by an increase in net sales of Europe of 30.3 percent.

Reliv reported net income of $503,000, or $0.04 per diluted share, for the fourth quarter of 2013 compared with net income of $437,000, or $0.03 per diluted share, for the fourth quarter of 2012. Income from operations for the fourth quarter of 2013 was $888,000 compared with $611,000 in the same quarter of 2012.

Full-Year Results

Reliv reported net sales of $68.2 million for 2013 compared with net sales of $68.7 million in 2012. U.S. net sales were essentially flat at $53.7 million in 2013, compared to $53.8 million in 2012. Net sales in Reliv's foreign markets for 2013 decreased 2.4 percent compared with net sales for 2012. Europe remained Reliv's biggest growth market, with net sales increasing by 22.7 percent.

Net income for 2013 was $777,000 compared with $1.4 million in 2012. Diluted earnings per share were $0.06 in 2013 compared with $0.11 in 2012. Net income for 2012 included a one-time after-tax gain of approximately $247,000 ($0.02 diluted EPS) resulting from a discounted balance due on a purchase agreement entered into in a previous year.

"The United States reported sales gains in both the third and fourth quarters of 2013, the first year-over-year quarterly gains in the United States in more than six years at Reliv," said Robert L. Montgomery, chairman and chief executive officer of Reliv. "U.S. growth led to an increase in net sales worldwide in the third and fourth quarters, up 8.3% and 2.8% respectively, over the same periods in 2012. We believe that an updated distributor compensation plan, sustained expansion in Europe and Reliv's position as a pioneer in the field of nutritional epigenetics create a solid foundation."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,429.53 +42.32 0.24%
S&P 500 2,029.60 +0.05 0.00%
NASDAQ 4,692.1180 +10.6210 0.23%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs